Project Grant R01NS136323
Award Date
9/1/24
Completion Date
5/31/29
Dollars Obligated
$1.1M
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55455, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research to identify electrophysiological mechanisms of freezing of gait (FOG) in Parkinson's disease. The $578,329 award to the University of California, Los Angeles will leverage invasive brain recordings and immersive virtual reality to characterize neural activity in the...
This federal Project Grant award of $476,643.00 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), supports research to study the neurophysiological basis of impaired gait in mouse models of Parkinson's disease. The key objectives are to examine how the dorsolateral striatum and substantia nigra pars reticulata, which are part of the basal ganglia, encode gait...
This $249,949 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports a study on imaging biomarkers of freezing of gait (FOG) response to deep brain stimulation (DBS) in Parkinson's disease patients. The key objectives are to: 1) identify differences in blood oxygen level dependent (BOLD) activation based on FOG response to DBS, 2)...
This federal Project Grant award, identified as F31NS137765, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $173,140 grant, awarded on Sep 30, 2024, supports research to investigate the role of neural activity in the degeneration of midbrain dopamine neurons, which is a key pathological process in Parkinson's disease. The project will utilize...
The Regents of the University of Minnesota will receive $4.67 million under a three-year Project Grant from the National Institute on Aging within the Department of Health and Human Services. The grant funds research under the Aging Research program (CFDA 93.866) to characterize neuroplastic changes and their relationship to emerging motor and cognitive deficits in individuals with isolated rapid eye movement sleep behavior disorder (IRBD). Over the period of performance from August 2022 through...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $469,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Michigan Technological University. The grant, titled "Dissecting Neural Circuit Mechanisms Underlying Pallidal Deep Brain Stimulation," will fund research to identify the neural elements and circuits necessary for the therapeutic effects of deep brain stimulation (DBS) of the globus...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $646,104 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the San Diego Biomedical Research Institute, a non-profit research organization. The grant supports research to investigate how neuroinflammation mediated by the interleukin-13 receptor signaling pathway may contribute to the selective loss of dopaminergic neurons in Parkinson's disease. The...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $676,731 to Arizona State University to identify specific aspects of balance and reactive stepping that are related to falls in people with Parkinson's disease (PD). The goals of this 5-year project are to: Assess the relationship between reactive balance, standing balance, and prospectively measured falls in 100 individuals with PD at risk for falls. This will identify the critical balance...
This $1,009,212 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research into a novel gene therapy approach to reduce neurotoxicity in Parkinson's disease. The primary awardee, Van Andel Research Institute (VAI), will conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to develop a gene therapy that aims to enhance the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA program 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, provides $670,600 to The Johns Hopkins University to conduct research on the role of microglia in Parkinson's disease (PD) cognitive and motor impairment. The research aims to better understand the relationship between a microglial-specific radioligand, [11C]CPPC, and the severity of...